Without policy intervention to address average sales price-based challenges to biosimilar market sustainability, there is a ...

Radioimmunotherapy using 225Ac, a highly cytotoxic α-particle emitter, has potential for treating advanced breast cancer, especially human epidermal growth factor receptor 2 (HER2)–positive cases. We ...

Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $851 million for the third quarter ended September 30, 2025, ...

Reports record revenue of $21.2 million for the third quarter of 2025, an increase of $2.9 million, or 16%, compared to the same period in 2024.Reports record GAAP diluted EPS ...

Discover why Alexandria Real Estate Equities is a top REIT pick for long-term gains and dividends after a price dip. Click ...

Vertex Pharmaceuticals Incorporated remains a leader in CF treatments, fueling robust cash flow and pipeline expansions.

The Asia Business Daily 'So Jongseop's Current Affairs Show'■ Host: Political Specialist So Jongseop■ Producer: Park Sumin■ ...

According to Chairman Xiao Ping, the company’s philosophy of "daring to break through, avoiding blind conformity, and ...

Leverage was 3.31x, as calculated under our First Lien Credit Agreement at September 30, 2025. The results of the Community Living business are included in such calculation pursuant to our First Lien ...

Alerus Financial Corporation , or the Company, reported net income of $16.9 million for the third quarter of 2025, or $0.65 per diluted common share, compared to net income of $20.3 million, or $0.78 ...